← Return to MCRC with peritoneal Mets. Is Immunotherapy an option?
DiscussionMCRC with peritoneal Mets. Is Immunotherapy an option?
Colorectal Cancer | Last Active: Jun 22 10:36am | Replies (11)Comment receiving replies
Replies to "Trial is PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal,..."
I would like to thank you for all the information you have provided. It is very pertinent and helpful, especially the March 2024 abstract which I had not seen before. You seem to be well educated in this area and I really appreciate your comments. I am a retired detective and for decades I conducted investigations for other people and now I am doing it for myself and sharing with others in my situation. Last year, I met with Dr Deperalta from Northwell, and I was put on the PIPAC waitlist. They called me in January, but I delayed it because my treatment was working well but they kept me on the list. I just had a dx lap and have been accepted and I am awaiting my first treatment.
After researching immunotherapy, I believe that it is the future and studies continually show it is safe and very effective and with Dr Morris and others researching MSS and BRAF the future is looking pretty exciting.
Thank you again for your input
God Bless,
Tim